ReviewDrugs & aging2014
Management of benign prostatic hyperplasia: role of phosphodiesterase-5 inhibitors.
M Gacci et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
4 papers cite it
this papercites it
ReviewDrugs & aging2014
M Gacci et al.PubMed ↗Publisher ↗
No numbers read from the abstract.